Janus Henderson Group PLC Novo Nordisk A S Transaction History

Janus Henderson Group PLC

  • $182 Billion
  • Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Janus Henderson Group PLC holds 893,597 shares of NVO stock, worth $114 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
893,597
Previous 1,317,710 32.19%
Holding current value
$114 Million
Previous $169 Million 24.61%
% of portfolio
0.07%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$122.71 - $146.91 $52 Million - $62.3 Million
-424,113 Reduced 32.19%
893,597 $128 Million
Q1 2024

May 15, 2024
SELL
$102.11 - $135.92 $25.7 Million - $34.2 Million
-251,854 Reduced 16.05%
1,317,710 $169 Million
Q4 2023

Feb 14, 2024
BUY
$87.78 - $105.45 $23.1 Million - $27.8 Million
263,279 Added 20.15%
1,569,564 $162 Million
Q3 2023

Nov 14, 2023
BUY
$90.94 - $199.54 $74.2 Million - $163 Million
815,674 Added 166.26%
1,306,285 $119 Million
Q2 2023

Aug 14, 2023
BUY
$155.98 - $172.65 $51.4 Million - $56.9 Million
329,415 Added 204.36%
490,611 $79.4 Million
Q1 2023

May 15, 2023
SELL
$132.34 - $159.14 $2.57 Million - $3.09 Million
-19,439 Reduced 10.76%
161,196 $25.7 Million
Q4 2022

Feb 14, 2023
SELL
$102.55 - $135.33 $270,014 - $356,323
-2,633 Reduced 1.44%
180,635 $24.4 Million
Q3 2022

Nov 14, 2022
SELL
$95.28 - $116.93 $115,669 - $141,953
-1,214 Reduced 0.66%
183,268 $18.3 Million
Q2 2022

Aug 15, 2022
SELL
$103.24 - $121.81 $1.19 Million - $1.41 Million
-11,569 Reduced 5.9%
184,482 $20.6 Million
Q1 2022

May 16, 2022
SELL
$93.1 - $112.54 $1.04 Million - $1.25 Million
-11,148 Reduced 5.38%
196,051 $21.8 Million
Q4 2021

Feb 14, 2022
SELL
$95.88 - $117.08 $1.05 Million - $1.28 Million
-10,947 Reduced 5.02%
207,199 $23.2 Million
Q3 2021

Nov 16, 2021
BUY
$84.42 - $106.62 $390,695 - $493,437
4,628 Added 2.17%
218,146 $20.9 Million
Q2 2021

Aug 16, 2021
SELL
$67.66 - $84.76 $158,933 - $199,101
-2,349 Reduced 1.09%
213,518 $17.9 Million
Q1 2021

May 17, 2021
BUY
$67.06 - $75.82 $1.39 Million - $1.57 Million
20,698 Added 10.61%
215,867 $14.6 Million
Q4 2020

Feb 16, 2021
SELL
$63.89 - $73.8 $2.84 Million - $3.28 Million
-44,385 Reduced 18.53%
195,169 $13.6 Million
Q3 2020

Nov 16, 2020
BUY
$63.69 - $70.22 $1.54 Million - $1.7 Million
24,211 Added 11.24%
239,554 $16.6 Million
Q2 2020

Aug 14, 2020
BUY
$58.54 - $67.94 $239,604 - $278,078
4,093 Added 1.94%
215,343 $14.1 Million
Q1 2020

May 14, 2020
SELL
$49.46 - $64.78 $322,528 - $422,430
-6,521 Reduced 2.99%
211,250 $12.7 Million
Q4 2019

Feb 18, 2020
SELL
$49.86 - $58.26 $1.21 Million - $1.41 Million
-24,198 Reduced 10.0%
217,771 $12.6 Million
Q3 2019

Nov 14, 2019
SELL
$47.54 - $53.43 $353,745 - $397,572
-7,441 Reduced 2.98%
241,969 $12.5 Million
Q2 2019

Jul 31, 2019
BUY
$46.79 - $52.47 $74,817 - $83,899
1,599 Added 0.65%
249,410 $12.7 Million
Q1 2019

Apr 30, 2019
BUY
$46.36 - $52.63 $1.18 Million - $1.34 Million
25,382 Added 11.41%
247,811 $13 Million
Q4 2018

Feb 06, 2019
BUY
$41.54 - $47.25 $568,101 - $646,191
13,676 Added 6.55%
222,429 $10.2 Million
Q3 2018

Nov 09, 2018
BUY
$46.76 - $51.24 $226,365 - $248,052
4,841 Added 2.37%
208,753 $9.84 Million
Q2 2018

Aug 10, 2018
SELL
$44.29 - $50.42 $269,991 - $307,360
-6,096 Reduced 2.9%
203,912 $9.4 Million
Q1 2018

May 14, 2018
SELL
$48.49 - $58.14 $332,253 - $398,375
-6,852 Reduced 3.16%
210,008 $10.3 Million
Q4 2017

Feb 09, 2018
BUY
$47.53 - $53.73 $362,463 - $409,744
7,626 Added 3.64%
216,860 $11.6 Million
Q3 2017

Nov 14, 2017
SELL
$41.15 - $49.22 $187,479 - $224,246
-4,556 Reduced 2.13%
209,234 $0
Q2 2017

Aug 17, 2017
BUY
N/A
213,790
213,790 $9.17 Million

Others Institutions Holding NVO

# of Institutions
1,991
Shares Held
318M
Call Options Held
5.23M
Put Options Held
4.97M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $288B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email